April 30 – Prescription drug costs: No magic pill

Patients across Wisconsin rely on innovative drug therapies for their health and well-being.

But, the rising cost of prescription drugs is threatening patient access and squeezing healthcare budgets. It’s also prompted finger pointing on who is to blame, preventing consensus on how to move forward.

Wisconsin Health News is assembling a virtual panel of experts to examine what more can be done to control costs and preserve access.

Panelists:

• Kevin Mead, National Director of Market Access – Strategic Accounts, Novo Nordisk
• Sean Stephenson, Director of State Affairs, Pharmaceutical Care Management Association
• Nathan Houdek, Commissioner of Insurance, State of Wisconsin
• Dr. Mark Huth, CEO, Group Health Cooperative of South Central Wisconsin

Register now.

WHN Virtual Panel Series is sponsored by:

The Alliance

Aurora Health Care

AARP Wisconsin

Anthem Blue Cross and Blue Shield of Wisconsin

Bellin+Gundersen Health System

Husch Blackwell

Quartz